Primary |
Product Used For Unknown Indication |
40.0% |
Renal Failure Chronic |
31.4% |
Nephrogenic Anaemia |
14.3% |
Anaemia |
8.6% |
Anaemia Of Malignant Disease |
2.9% |
Drug Use For Unknown Indication |
2.9% |
|
Aplasia Pure Red Cell |
63.0% |
Anaemia |
7.4% |
Anti-erythropoietin Antibody Positive |
7.4% |
Pleural Effusion |
7.4% |
Renal Failure |
7.4% |
Neutralising Antibodies Positive |
3.7% |
Oedema |
3.7% |
|
Secondary |
Nephrogenic Anaemia |
28.8% |
Hypertension |
10.0% |
Diabetes Mellitus |
7.3% |
Hyperphosphataemia |
7.3% |
Renal Failure Chronic |
5.0% |
Hyperuricaemia |
4.1% |
Asthma |
3.7% |
Cardiac Failure |
3.7% |
Constipation |
3.7% |
Gastric Ulcer |
3.7% |
Hyperlipidaemia |
3.7% |
Hypocalcaemia |
3.7% |
Hyperparathyroidism Secondary |
2.7% |
Product Used For Unknown Indication |
2.7% |
Diarrhoea |
1.8% |
Gastritis |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Mesenteric Artery Thrombosis |
1.8% |
Zinc Deficiency |
1.8% |
Renal Failure |
0.9% |
|
Anti-erythropoietin Antibody Positive |
22.7% |
Bronchitis |
18.2% |
Aplasia Pure Red Cell |
11.4% |
Anaemia |
9.1% |
Haemoglobin Decreased |
9.1% |
Haemorrhoidal Haemorrhage |
4.5% |
Platelet Count Decreased |
4.5% |
Renal Haemorrhage |
4.5% |
Renal Impairment |
4.5% |
Hyperkalaemia |
2.3% |
Lip Haemorrhage |
2.3% |
Nausea |
2.3% |
Nephrogenic Anaemia |
2.3% |
Nephrosclerosis |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
32.8% |
Hypertension |
12.5% |
Hyperphosphataemia |
10.4% |
Renal Failure Chronic |
6.1% |
Nephrogenic Anaemia |
5.2% |
Hyperparathyroidism Secondary |
3.5% |
Insomnia |
3.2% |
Rash |
3.0% |
Cardiac Failure Chronic |
2.9% |
Type 2 Diabetes Mellitus |
2.5% |
Gastritis |
2.4% |
Constipation |
2.1% |
Osteoarthritis |
1.8% |
Prophylaxis |
1.8% |
Pruritus |
1.8% |
Diabetes Mellitus |
1.7% |
Gastrooesophageal Reflux Disease |
1.6% |
Hepatitis C |
1.6% |
Prostate Cancer |
1.5% |
Anaemia |
1.4% |
|
Myocardial Ischaemia |
12.5% |
Anaemia |
10.9% |
Peritoneal Dialysis Complication |
6.3% |
Renal Impairment |
6.3% |
Dermal Cyst |
4.7% |
Haemoglobin Decreased |
4.7% |
Hyperparathyroidism Secondary |
4.7% |
Hypoglycaemic Unconsciousness |
4.7% |
Pancytopenia |
4.7% |
Renal Haemorrhage |
4.7% |
Rhabdomyolysis |
4.7% |
Small Intestinal Perforation |
4.7% |
Vomiting |
4.7% |
Angina Pectoris |
3.1% |
Azotaemia |
3.1% |
Blood Creatinine Increased |
3.1% |
Blood Uric Acid Increased |
3.1% |
Bradycardia |
3.1% |
Cardiac Failure Acute |
3.1% |
Cerebral Haemorrhage |
3.1% |
|